Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Evolution Esophageal Stent Fully Covered

Research Leaders

8 sponsors active, led by Quovadis Associazione

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 2 (1)

Trial Status

Completed4
Unknown1
Withdrawn1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Evolution Esophageal Stent Fully Covered1
  • Miniinvasive Esophagoscopy1
  • Fully Covered Selfexpanding Metal Stents Fcsems1
  • Fcsems With No Suturing Ns1
  • Observational1

Active Sponsors

  • Quovadis Associazione1
  • Abbott1
  • Cook Group Incorporated1
  • Johns Hopkins University1
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Top Investigators

Related Conditions

  • Esophageal Fistula4
  • Esophageal Perforation Traumatic2
  • Esophageal Strictures1
  • Esophageal Stenosis1
  • Stents1

Activity Timeline